We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gear Up for Idexx (IDXX) Q3 Earnings: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Idexx Laboratories (IDXX - Free Report) is expected to reveal quarterly earnings of $3.71 per share, indicating an increase of 9.1% compared to the year-ago period. Analysts forecast revenues of $1.19 billion, representing an increase of 7.5% year over year.
The consensus EPS estimate for the quarter has been revised 0.2% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Given this perspective, it's time to examine the average forecasts of specific Idexx metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Revenue- Other' will reach $4.42 million. The estimate points to a change of -1% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Livestock and poultry diagnostics (LPD)' at $35.13 million. The estimate points to a change of +3.5% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenue- Water' of $57.79 million. The estimate suggests a change of +6.4% year over year.
Analysts forecast 'Revenue- Companion Animal Group (CAG)' to reach $1.09 billion. The estimate indicates a change of +7.9% from the prior-year quarter.
The consensus estimate for 'Revenue- Companion Animal Group (CAG)- United States' stands at $720.14 million. The estimate points to a change of +7.7% from the year-ago quarter.
Analysts' assessment points toward 'Revenue- Companion Animal Group (CAG)- International' reaching $375.58 million. The estimate points to a change of +9.1% from the year-ago quarter.
Analysts expect 'Revenue- LPD- International' to come in at $27.29 million. The estimate suggests a change of +0.8% year over year.
The combined assessment of analysts suggests that 'Revenue- Water- International' will likely reach $27.18 million. The estimate indicates a year-over-year change of +3.6%.
It is projected by analysts that the 'Revenue- LPD- United States' will reach $7.28 million. The estimate indicates a change of +6% from the prior-year quarter.
The consensus among analysts is that 'Percent of Revenue- Gross Profit - CAG' will reach 62.4%. The estimate is in contrast to the year-ago figure of 62.0%.
Based on the collective assessment of analysts, 'Percent of Revenue- Gross Profit - LPD' should arrive at 48.0%. Compared to the present estimate, the company reported 47.0% in the same quarter last year.
According to the collective judgment of analysts, 'Percent of Revenue- Gross Profit - Water' should come in at 70.0%. Compared to the current estimate, the company reported 70.1% in the same quarter of the previous year.
Over the past month, Idexx shares have recorded returns of +5.2% versus the Zacks S&P 500 composite's -0.2% change. Based on its Zacks Rank #2 (Buy), IDXX will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Image: Bigstock
Gear Up for Idexx (IDXX) Q3 Earnings: Wall Street Estimates for Key Metrics
The upcoming report from Idexx Laboratories (IDXX - Free Report) is expected to reveal quarterly earnings of $3.71 per share, indicating an increase of 9.1% compared to the year-ago period. Analysts forecast revenues of $1.19 billion, representing an increase of 7.5% year over year.
The consensus EPS estimate for the quarter has been revised 0.2% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Given this perspective, it's time to examine the average forecasts of specific Idexx metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Revenue- Other' will reach $4.42 million. The estimate points to a change of -1% from the year-ago quarter.
The average prediction of analysts places 'Revenue- Livestock and poultry diagnostics (LPD)' at $35.13 million. The estimate points to a change of +3.5% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenue- Water' of $57.79 million. The estimate suggests a change of +6.4% year over year.
Analysts forecast 'Revenue- Companion Animal Group (CAG)' to reach $1.09 billion. The estimate indicates a change of +7.9% from the prior-year quarter.
The consensus estimate for 'Revenue- Companion Animal Group (CAG)- United States' stands at $720.14 million. The estimate points to a change of +7.7% from the year-ago quarter.
Analysts' assessment points toward 'Revenue- Companion Animal Group (CAG)- International' reaching $375.58 million. The estimate points to a change of +9.1% from the year-ago quarter.
Analysts expect 'Revenue- LPD- International' to come in at $27.29 million. The estimate suggests a change of +0.8% year over year.
The combined assessment of analysts suggests that 'Revenue- Water- International' will likely reach $27.18 million. The estimate indicates a year-over-year change of +3.6%.
It is projected by analysts that the 'Revenue- LPD- United States' will reach $7.28 million. The estimate indicates a change of +6% from the prior-year quarter.
The consensus among analysts is that 'Percent of Revenue- Gross Profit - CAG' will reach 62.4%. The estimate is in contrast to the year-ago figure of 62.0%.
Based on the collective assessment of analysts, 'Percent of Revenue- Gross Profit - LPD' should arrive at 48.0%. Compared to the present estimate, the company reported 47.0% in the same quarter last year.
According to the collective judgment of analysts, 'Percent of Revenue- Gross Profit - Water' should come in at 70.0%. Compared to the current estimate, the company reported 70.1% in the same quarter of the previous year.
View all Key Company Metrics for Idexx here>>>Over the past month, Idexx shares have recorded returns of +5.2% versus the Zacks S&P 500 composite's -0.2% change. Based on its Zacks Rank #2 (Buy), IDXX will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .